Investors are starting to focus on what will replace compounded GLP-1 as a growth driver for telehea...
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Investors are starting to focus on what will replace compounded GLP-1 as a growth driver for telehealth companies like Hims & Hers Health.
Author: CNBC
Read Original Article